» Authors » Marcia Dalastra Laurenti

Marcia Dalastra Laurenti

Explore the profile of Marcia Dalastra Laurenti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 613
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Gonzalez K, Calzada J, Tomokane T, Pacheco C, Araujo Flores G, Castro Gomes C, et al.
Parasite Immunol . 2020 Oct; 43(3):e12801. PMID: 33068443
Aims: Leishmaniasis is considered a disease with multiple clinical/immunopathological characteristics, depending on the immunity of the host and the species of the parasite. In Panama, the most prevalent species that...
22.
Galvis-Ovallos F, Ueta A, Marques G, Sarmento A, Araujo G, Sandoval C, et al.
J Med Entomol . 2020 Oct; 58(2):830-836. PMID: 33047129
Visceral leishmaniasis is spreading in Brazil where the main vector of its agent, Leishmania infantum Nicolle, 1908, is the Lutzomyia longipalpis (Lutz & Neiva, 1912) species complex (Diptera: Psychodidae: Phlebotominae),...
23.
Fernandez-Garcia R, Statts L, de Jesus J, Dea-Ayuela M, Bautista L, Simao R, et al.
ACS Infect Dis . 2020 Aug; 6(10):2647-2660. PMID: 32810398
Cutaneous fungal and parasitic diseases remain challenging to treat, as available therapies are unable to permeate the skin barrier. Thus, treatment options rely on systemic therapy, which fail to produce...
24.
da Silva T, Silveira F, Tomokane T, Batista L, Nunes J, Matta V, et al.
Parasitol Int . 2020 Aug; 79:102177. PMID: 32791320
Although there is a great diversity of techniques and antigens used in the serodiagnosis of canine visceral leishmaniasis (CVL), total sensitivity and specificity have not yet been found. Since the...
25.
Lalatsa A, Statts L, de Jesus J, Adewusi O, Dea-Ayuela M, Bolas-Fernandez F, et al.
Int J Pharm . 2020 Aug; 588:119734. PMID: 32777535
Leishmaniasis is a neglected disease presenting cutaneous, mucosal and visceral forms and affecting an estimated 12 million mostly low-income people. Treatment of cutaneous leishmaniasis (CL) is recommended to expedite healing,...
26.
Sosa-Ochoa W, Zuniga C, Chaves L, Araujo Flores G, Pacheco C, Matta V, et al.
Pathogens . 2020 Jul; 9(7). PMID: 32664223
is the etiological agent of both American visceral leishmaniasis (AVL) and non-ulcerated cutaneous leishmaniasis (NUCL) in Honduras. Although AVL is the most severe clinical form of infection, recent studies have...
27.
Yamamoto E, de Jesus J, Bezerra-Souza A, Brito J, Lago J, Laurenti M, et al.
Bioorg Chem . 2020 Jul; 102:104056. PMID: 32653607
Leishmaniasis is an infectious disease caused by protozoan parasites of the genus Leishmania. The treatment of all forms of leishmaniasis relies on first-line drug, pentavalent antimonial, and in cases of...
28.
Araujo Flores G, Pacheco C, Ochoa W, Castro Gomes C, Zuniga C, Corbett C, et al.
Parasite Immunol . 2020 Jul; 42(11):e12772. PMID: 32603482
Skin lesions in nonulcerated cutaneous leishmaniasis (NUCL) caused by Leishmania (L.) infantum chagasi are characterized by a mononuclear inflammatory infiltrate in the dermis, which is composed mainly of lymphocytes, followed...
29.
Hirata K, Oliveira Sobrinho E, Rigon L, Utsunomiya Y, Tomokane T, Laurenti M, et al.
Rev Soc Bras Med Trop . 2019 Dec; 53:e20190320. PMID: 31859954
Introduction: This study aimed to investigate human exposure to Leishmania spp. infection and sandflies in an area endemic for the disease. Methods: The presence of antibodies specific for Leishmania spp....
30.
Bezerra-Souza A, Fernandez-Garcia R, Rodrigues G, Bolas-Fernandez F, Laurenti M, Passero L, et al.
Pharmaceutics . 2019 Jul; 11(7). PMID: 31330776
Leishmaniasis is a neglected tropical disease affecting more than 12 million people worldwide, which in its visceral clinical form (VL) is characterised by the accumulation of parasites in the liver...